(Created page with "{{Infobox drug reference | trade_names =Byfavo | drug_class =Sedative hypnotic | drug_class_color =benzodiazepine | uses =Sedation | contraindications = | routes =Intrave...")
 
m (Added embedded dosage calculation)
 
Line 1: Line 1:
{{Infobox drug reference
{{Infobox drug reference
| trade_names =Byfavo  
| trade_names = Byfavo
| drug_class =Sedative hypnotic  
| drug_class = Sedative hypnotic
| drug_class_color =benzodiazepine  
| drug_class_color = benzodiazepine
| uses =Sedation  
| uses = Sedation
| contraindications =  
| contraindications =  
| routes =Intravenous  
| routes = Intravenous
| dosage =  
| dosage =  
|mechanism=GABA agonism|adverse_effects=|time_onset=|duration=|metabolism=|halflife_redistribution=|halflife_elimination=|clearance=|protein_binding=}}
| dosage_calculation = remimazolam
| mechanism = GABA agonism
| adverse_effects =  
| time_onset =  
| duration =  
| metabolism =  
| halflife_redistribution =  
| halflife_elimination =  
| clearance =  
| protein_binding =  
}}


Provide a brief summary of this drug here.
Provide a brief summary of this drug here.

Latest revision as of 00:14, 30 March 2022

Remimazolam
Trade names

Byfavo

Clinical data
Drug class

Sedative hypnotic

Uses

Sedation

Routes of administration

Intravenous

Dosage
Adult dosing
  • 2.5-5 mg IV q2m
  • 2.5-5 mL of 1 mg/mL
Indication 
Monitored anesthesia care
Route 
Intravenous
Preparation 
1 mg/mL
Pharmacodynamics
Mechanism of action

GABA agonism

Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References